Everdime Technologies, Inc.
RGST · OTC
3/31/2024 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $247 | $0 | $94 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $109 | $0 | $0 | $12 |
| Gross Profit | $138 | $0 | $94 | -$12 |
| % Margin | 55.9% | – | 100% | – |
| R&D Expenses | $0 | $35 | $36 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $96 | $55 | $56 | $419 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $96 | $90 | $91 | $422 |
| Operating Income | $42 | -$90 | $3 | -$434 |
| % Margin | 17.1% | – | 2.9% | – |
| Other Income/Exp. Net | -$3 | $16 | -$0 | $0 |
| Pre-Tax Income | $39 | -$73 | $2 | -$434 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $39 | -$73 | $2 | -$434 |
| % Margin | 16% | – | 2.6% | – |
| EPS | 0 | -0.001 | 0 | -0.003 |
| % Growth | 160% | -3,253.3% | 100.6% | – |
| EPS Diluted | 0 | -0.001 | 0 | -0.003 |
| Weighted Avg Shares Out | 155,583 | 155,583 | 155,583 | 155,038 |
| Weighted Avg Shares Out Dil | 155,583 | 155,583 | 155,583 | 155,038 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $0 | $0 | $0 |
| Depreciation & Amortization | $15 | -$40 | $122 | $12 |
| EBITDA | $56 | -$90 | $3 | -$422 |
| % Margin | 22.7% | – | 2.9% | – |